Results 91 to 100 of about 24,045,029 (163)

A systematic review on nutraceuticals as a potential source of therapeutics against COVID-19 and other emerging viral diseases

open access: yesDiscover Applied Sciences
COVID-19 is a respiratory viral disease caused by acute respiratory syndrome coronavirus (SARS-CoV) that resulted in a significant pandemic. There is currently no effective antiviral medication to fight the deadly and extremely contagious COVID-19 virus.
Pankaj Singh   +6 more
doaj   +1 more source

Hepatitis B virus vaccination of silvery gibbons (Hylobates moloch) at the Perth Zoo [PDF]

open access: yes, 2003
Hepatitis B virus (HEV) has been identified in a number of nonhuman primate species, including the Silvery gibbon (Hylobates moloch). The Perth Zoo has a successful Silvery gibbon breeding program and has developed an HBV vaccination regime to protect ...
Fenwick, S.   +5 more
core  

Unmasking Hepatitis A: A Case Study of Atypical Presentation in a Returning Traveler From Egypt

open access: yesCase Reports in Hepatology
Hepatitis, characterized by inflammation of the liver, arises from various infectious and noninfectious causes, with viral hepatitis being caused by a diverse group of viruses including hepatitis A, B, C, D, and E.
Emmanuel Edwar Siddig   +2 more
doaj   +1 more source

A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection

open access: yesThe Journal of Clinical Investigation
Sustained CD4+ T cell immunity is required for resolution of acute hepatitis C virus (HCV) infection, but the response remains poorly characterized.
Heather Blasczyk   +10 more
doaj   +1 more source

Plant-Based Virus-like Particle (VLP) Vaccines Against Influenza and Hepatitis Viruses. [PDF]

open access: yesVaccines (Basel)
Shahgolzari M   +7 more
europepmc   +1 more source

Hepatitis C : proposed expansion of testing recommendations, 2012 [PDF]

open access: yes
Hepatitis C is an unrecognized health crisis in the United States. This life-threatening infection affects an estimated 3.2 million Americans, most of whom are \u201cbaby boomers\u201d (those born from 1945 through 1965).

core  

MDL-001: An Oral, Direct-Acting Broad-Spectrum Antiviral for Influenza-like Illness (ILI) and Chronic Hepatitis In Vivo. [PDF]

open access: yesPharmaceuticals (Basel)
Woods V   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy